2016
DOI: 10.5958/2349-2988.2016.00001.2
|View full text |Cite
|
Sign up to set email alerts
|

Spectrophotometric Method Development and Validation of Prazosin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…1). From the literature survey some supporting information were referred in the present research work such as, validated specific HPLC method for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH recommended stress conditions (Bakshi et al,, 2004), determination of terazosin by MBTH and BPB reagents using spectrophotometric technique (Ramachandra and Naidu, 2016), Spectrophotometry method for the determination of Terazosin in tablet formulation (Shrivastava and Dhakad, 2016), stability indicating RP-HPLC method for the simultaneous determination of Prazosin, terazosin, Doxazosin in pharmaceutical formulations (Shrivastava and Gupta, 2012), stability indicating HPTLC determination of Terazosin in tablet formulation (Shrivastava et al, 2013), Spectrophotometric method development and validation of prazosin (Nikam et al, 2016), a new validated spectrophotometric method for the estimation of rabeprazole sodium in tablet dosage form (Domatoti andKoppula, 2012) and Stress degradation studies on telmisartan and development of a validated method by UV spectrophotometry in bulk and pharmaceutical dosage forms (Patel et al, 2011). There are a few available literatures which explain the method development, validation and stability studies for estimation of Terazosin by UV-Spectrophotometric method.…”
Section: Introductionmentioning
confidence: 99%
“…1). From the literature survey some supporting information were referred in the present research work such as, validated specific HPLC method for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH recommended stress conditions (Bakshi et al,, 2004), determination of terazosin by MBTH and BPB reagents using spectrophotometric technique (Ramachandra and Naidu, 2016), Spectrophotometry method for the determination of Terazosin in tablet formulation (Shrivastava and Dhakad, 2016), stability indicating RP-HPLC method for the simultaneous determination of Prazosin, terazosin, Doxazosin in pharmaceutical formulations (Shrivastava and Gupta, 2012), stability indicating HPTLC determination of Terazosin in tablet formulation (Shrivastava et al, 2013), Spectrophotometric method development and validation of prazosin (Nikam et al, 2016), a new validated spectrophotometric method for the estimation of rabeprazole sodium in tablet dosage form (Domatoti andKoppula, 2012) and Stress degradation studies on telmisartan and development of a validated method by UV spectrophotometry in bulk and pharmaceutical dosage forms (Patel et al, 2011). There are a few available literatures which explain the method development, validation and stability studies for estimation of Terazosin by UV-Spectrophotometric method.…”
Section: Introductionmentioning
confidence: 99%